Could it be that we have a new rumor going around? Perhaps that the earnings announcement scheduled for later this month will not meet expectations? That might be designed to drive down the price so that the bigger players can add to their positions while waiting for the FDA approval of the new product.
What are you talking about? There ain't no earnings announcement later this month. What you have here is profit taking, momentum to the downside, no announcement of the Premier instrument approval in China (which is overdue), and unattractive valuation (for the time being until the company-touted Fiomi cardiac instruments take shape ).